(3R,4S,5S,6R)-2-((2,4-dibromo-6-((cyclohexyl(methyl)amino) methyl)phenyl)amino)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol compound with (2R,3R,4R,5S,E)-6-((2,4-dibromo-6-((cyclohexyl(methyl)amino)methyl)phenyl)imino)hexane-1,2,3,4,5-pentaol
Bromhexine Impurity 13 (Bromhexine D-Glucose Derivative) (Mixture of Isomers) is a fully characterized chemical compound used as a reference standard of API Bromhexine. The standard offered is compliant with regulatory guidelines. Bromhexine Impurity 13 (Bromhexine D-Glucose Derivative) (Mixture of Isomers) is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - NA
Related products
Bromhexine Related Compound 1 HCl
M.F.
M.W. 331.69 36.46
CAT# AR-B02100
CAS# 1631131-52-6 (free base)
